GenomeNet

Database: UniProt
Entry: SRPRA_HUMAN
LinkDB: SRPRA_HUMAN
Original site: SRPRA_HUMAN 
ID   SRPRA_HUMAN             Reviewed;         638 AA.
AC   P08240; A6NIB3; B2R5Z8; B4E0H3; E9PJS4; Q9BVJ4;
DT   01-AUG-1988, integrated into UniProtKB/Swiss-Prot.
DT   02-MAY-2002, sequence version 2.
DT   27-MAR-2024, entry version 219.
DE   RecName: Full=Signal recognition particle receptor subunit alpha;
DE            Short=SR-alpha;
DE   AltName: Full=Docking protein alpha;
DE            Short=DP-alpha;
GN   Name=SRPRA {ECO:0000312|HGNC:HGNC:11307}; Synonyms=SRPR;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=3340536; DOI=10.1093/nar/16.1.361;
RA   Hortsch M., Labeit S., Meyer D.I.;
RT   "Complete cDNA sequence coding for human docking protein.";
RL   Nucleic Acids Res. 16:361-362(1988).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Amygdala, and Thymus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16554811; DOI=10.1038/nature04632;
RA   Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K.,
RA   Lloyd C., Itoh T., Takeda T., Kim D.-W., She X., Barlow K.F., Bloom T.,
RA   Bruford E., Chang J.L., Cuomo C.A., Eichler E., FitzGerald M.G.,
RA   Jaffe D.B., LaButti K., Nicol R., Park H.-S., Seaman C., Sougnez C.,
RA   Yang X., Zimmer A.R., Zody M.C., Birren B.W., Nusbaum C., Fujiyama A.,
RA   Hattori M., Rogers J., Lander E.S., Sakaki Y.;
RT   "Human chromosome 11 DNA sequence and analysis including novel gene
RT   identification.";
RL   Nature 440:497-500(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Lung, Muscle, and Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=15592455; DOI=10.1038/nbt1046;
RA   Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,
RA   Zha X.-M., Polakiewicz R.D., Comb M.J.;
RT   "Immunoaffinity profiling of tyrosine phosphorylation in cancer cells.";
RL   Nat. Biotechnol. 23:94-101(2005).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in signaling
RT   networks.";
RL   Cell 127:635-648(2006).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-296; SER-297 AND SER-298, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.m111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C., Meinnel T.,
RA   Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-177; SER-473 AND THR-578, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-284; SER-296; SER-297 AND
RP   SER-298, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [15]
RP   INTERACTION WITH ZIKA VIRUS FRENCH POLYNESIA 10087PF/2013 NS4A; ZIKA VIRUS
RP   MR-766 NS4A AND DENGUE VIRUS DENV2 16681 NS4A.
RX   PubMed=30550790; DOI=10.1016/j.cell.2018.11.028;
RA   Shah P.S., Link N., Jang G.M., Sharp P.P., Zhu T., Swaney D.L.,
RA   Johnson J.R., Von Dollen J., Ramage H.R., Satkamp L., Newton B.,
RA   Huettenhain R., Petit M.J., Baum T., Everitt A., Laufman O., Tassetto M.,
RA   Shales M., Stevenson E., Iglesias G.N., Shokat L., Tripathi S.,
RA   Balasubramaniam V., Webb L.G., Aguirre S., Willsey A.J., Garcia-Sastre A.,
RA   Pollard K.S., Cherry S., Gamarnik A.V., Marazzi I., Taunton J.,
RA   Fernandez-Sesma A., Bellen H.J., Andino R., Krogan N.J.;
RT   "Comparative Flavivirus-Host Protein Interaction Mapping Reveals Mechanisms
RT   of Dengue and Zika Virus Pathogenesis.";
RL   Cell 175:1931-1945(2018).
RN   [16]
RP   X-RAY CRYSTALLOGRAPHY (2.45 ANGSTROMS) OF 3-176 IN COMPLEX WITH SRPRB,
RP   FUNCTION, AND SUBUNIT.
RX   PubMed=16439358; DOI=10.1074/jbc.m512415200;
RA   Schlenker O., Hendricks A., Sinning I., Wild K.;
RT   "The structure of the mammalian signal recognition particle (SRP) receptor
RT   as prototype for the interaction of small GTPases with Longin domains.";
RL   J. Biol. Chem. 281:8898-8906(2006).
RN   [17]
RP   STRUCTURE BY ELECTRON MICROSCOPY (7.4 ANGSTROMS) OF 3-176 OF SIGNAL
RP   RECOGNITION PARTICLE IN COMPLEX WITH THE 80S RIBOSOME AND THE SRP RECEPTOR,
RP   AND FUNCTION.
RX   PubMed=16675701; DOI=10.1126/science.1124864;
RA   Halic M., Gartmann M., Schlenker O., Mielke T., Pool M.R., Sinning I.,
RA   Beckmann R.;
RT   "Signal recognition particle receptor exposes the ribosomal translocon
RT   binding site.";
RL   Science 312:745-747(2006).
RN   [18] {ECO:0007744|PDB:7NFX}
RP   STRUCTURE BY ELECTRON MICROSCOPY (3.20 ANGSTROMS) OF SIGNAL RECOGNITION
RP   PARTICLE IN COMPLEX WITH RIBOSOME NASCENT CHAIN COMPLEX AND THE SRP
RP   RECEPTOR, FUNCTION, INTERACTION WITH SRP54, AND MUTAGENESIS OF ARG-407.
RX   PubMed=34020957; DOI=10.1126/sciadv.abg0942;
RA   Lee J.H., Jomaa A., Jomaa A., Chung S., Hwang Fu Y.H., Qian R., Sun X.,
RA   Hsieh H.H., Chandrasekar S., Bi X., Mattei S., Boehringer D., Weiss S.,
RA   Ban N., Shan S.O.;
RT   "Receptor compaction and GTPase rearrangement drive SRP-mediated
RT   cotranslational protein translocation into the ER.";
RL   Sci. Adv. 7:942-942(2021).
CC   -!- FUNCTION: Component of the signal recognition particle (SRP) complex
CC       receptor (SR) (PubMed:16439358). Ensures, in conjunction with the SRP
CC       complex, the correct targeting of the nascent secretory proteins to the
CC       endoplasmic reticulum membrane system (PubMed:16675701,
CC       PubMed:34020957). Forms a guanosine 5'-triphosphate (GTP)-dependent
CC       complex with the SRP subunit SRP54 (PubMed:34020957). SRP receptor
CC       compaction and GTPase rearrangement drive SRP-mediated cotranslational
CC       protein translocation into the ER (PubMed:34020957).
CC       {ECO:0000269|PubMed:16439358, ECO:0000269|PubMed:16675701,
CC       ECO:0000269|PubMed:34020957}.
CC   -!- SUBUNIT: Heterodimer with SRPRB (PubMed:16439358). Interacts with the
CC       signal recognition particle (SRP) complex subunit SRP54
CC       (PubMed:34020957). {ECO:0000269|PubMed:16439358,
CC       ECO:0000269|PubMed:34020957}.
CC   -!- SUBUNIT: (Microbial infection) May interact with Zika virus strain Mr-
CC       766 non-structural protein 4A/NS4A (PubMed:30550790). May interact with
CC       Zika virus French Polynesia 10087PF/2013 non-structural protein 4A/NS4A
CC       (PubMed:30550790). {ECO:0000269|PubMed:30550790}.
CC   -!- SUBUNIT: (Microbial infection) May interact with Dengue virus DENV2
CC       16681 non-structural protein 4A/NS4A. {ECO:0000269|PubMed:30550790}.
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000250|UniProtKB:P32916}; Peripheral membrane protein
CC       {ECO:0000250|UniProtKB:P32916}; Cytoplasmic side
CC       {ECO:0000250|UniProtKB:P32916}. Note=Thought to be anchored in the
CC       membrane through an interaction with SR-beta, which contains a bona
CC       fide transmembrane domain. {ECO:0000250|UniProtKB:P32916}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P08240-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P08240-2; Sequence=VSP_046055;
CC   -!- DOMAIN: The NG domain region, also named G domain, is a special
CC       guanosine triphosphatase (GTPase) domain, which forms a guanosine 5'-
CC       triphosphate (GTP)-dependent complex with a homologous NG domain in the
CC       signal recognition particle (SRP) complex subunit SRP54
CC       (PubMed:34020957). The two NG domains undergo cooperative
CC       rearrangements upon their assembly, which culminate in the reciprocal
CC       activation of the GTPase activity of one another (PubMed:34020957).
CC       GTPase induced rearrangement of SR drives SRP-mediated cotranslational
CC       protein translocation into the ER (PubMed:34020957).
CC       {ECO:0000269|PubMed:34020957}.
CC   -!- SIMILARITY: Belongs to the GTP-binding SRP family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X06272; CAA29608.1; -; mRNA.
DR   EMBL; AK303379; BAG64435.1; -; mRNA.
DR   EMBL; AK312377; BAG35295.1; -; mRNA.
DR   EMBL; AP001318; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471065; EAW67686.1; -; Genomic_DNA.
DR   EMBL; BC001162; AAH01162.1; -; mRNA.
DR   EMBL; BC009110; AAH09110.1; -; mRNA.
DR   EMBL; BC013583; AAH13583.1; -; mRNA.
DR   CCDS; CCDS31717.1; -. [P08240-1]
DR   CCDS; CCDS53722.1; -. [P08240-2]
DR   PIR; A29440; A29440.
DR   RefSeq; NP_001171313.1; NM_001177842.1. [P08240-2]
DR   RefSeq; NP_003130.2; NM_003139.3. [P08240-1]
DR   PDB; 2FH5; X-ray; 2.45 A; A=3-176.
DR   PDB; 2GO5; EM; 7.40 A; 1=3-176.
DR   PDB; 5L3Q; X-ray; 3.20 A; B/D=1-638.
DR   PDB; 6Y32; X-ray; 2.60 A; B/D/F/H=332-638.
DR   PDB; 7NFX; EM; 3.20 A; y=1-638.
DR   PDBsum; 2FH5; -.
DR   PDBsum; 2GO5; -.
DR   PDBsum; 5L3Q; -.
DR   PDBsum; 6Y32; -.
DR   PDBsum; 7NFX; -.
DR   AlphaFoldDB; P08240; -.
DR   EMDB; EMD-12303; -.
DR   SMR; P08240; -.
DR   BioGRID; 112612; 302.
DR   ComplexPortal; CPX-630; Signal recognition particle receptor complex.
DR   IntAct; P08240; 100.
DR   MINT; P08240; -.
DR   STRING; 9606.ENSP00000328023; -.
DR   ChEMBL; CHEMBL4105934; -.
DR   GlyGen; P08240; 5 sites, 1 O-linked glycan (4 sites).
DR   iPTMnet; P08240; -.
DR   MetOSite; P08240; -.
DR   PhosphoSitePlus; P08240; -.
DR   SwissPalm; P08240; -.
DR   BioMuta; SRPRA; -.
DR   DMDM; 20455516; -.
DR   EPD; P08240; -.
DR   jPOST; P08240; -.
DR   MassIVE; P08240; -.
DR   MaxQB; P08240; -.
DR   PaxDb; 9606-ENSP00000328023; -.
DR   PeptideAtlas; P08240; -.
DR   ProteomicsDB; 21234; -.
DR   ProteomicsDB; 52097; -. [P08240-1]
DR   Pumba; P08240; -.
DR   Antibodypedia; 32980; 174 antibodies from 22 providers.
DR   DNASU; 6734; -.
DR   Ensembl; ENST00000332118.11; ENSP00000328023.5; ENSG00000182934.12. [P08240-1]
DR   Ensembl; ENST00000532259.1; ENSP00000435508.1; ENSG00000182934.12. [P08240-2]
DR   GeneID; 6734; -.
DR   KEGG; hsa:6734; -.
DR   MANE-Select; ENST00000332118.11; ENSP00000328023.5; NM_003139.4; NP_003130.2.
DR   UCSC; uc001qdh.4; human. [P08240-1]
DR   AGR; HGNC:11307; -.
DR   CTD; 6734; -.
DR   DisGeNET; 6734; -.
DR   GeneCards; SRPRA; -.
DR   HGNC; HGNC:11307; SRPRA.
DR   HPA; ENSG00000182934; Low tissue specificity.
DR   MalaCards; SRPRA; -.
DR   MIM; 182180; gene.
DR   neXtProt; NX_P08240; -.
DR   OpenTargets; ENSG00000182934; -.
DR   PharmGKB; PA36131; -.
DR   VEuPathDB; HostDB:ENSG00000182934; -.
DR   eggNOG; KOG0781; Eukaryota.
DR   GeneTree; ENSGT00550000074936; -.
DR   HOGENOM; CLU_009301_8_0_1; -.
DR   InParanoid; P08240; -.
DR   OMA; HLGWIDK; -.
DR   OrthoDB; 5475029at2759; -.
DR   PhylomeDB; P08240; -.
DR   TreeFam; TF106189; -.
DR   BRENDA; 3.6.5.4; 2681.
DR   PathwayCommons; P08240; -.
DR   Reactome; R-HSA-1799339; SRP-dependent cotranslational protein targeting to membrane.
DR   Reactome; R-HSA-381038; XBP1(S) activates chaperone genes.
DR   SignaLink; P08240; -.
DR   SIGNOR; P08240; -.
DR   BioGRID-ORCS; 6734; 598 hits in 1145 CRISPR screens.
DR   ChiTaRS; SRPRA; human.
DR   EvolutionaryTrace; P08240; -.
DR   GenomeRNAi; 6734; -.
DR   Pharos; P08240; Tchem.
DR   PRO; PR:P08240; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   RNAct; P08240; Protein.
DR   Bgee; ENSG00000182934; Expressed in parotid gland and 205 other cell types or tissues.
DR   Genevisible; P08240; HS.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IBA:GO_Central.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0016020; C:membrane; IDA:MGI.
DR   GO; GO:0005785; C:signal recognition particle receptor complex; EXP:ComplexPortal.
DR   GO; GO:0016887; F:ATP hydrolysis activity; IEA:InterPro.
DR   GO; GO:0005525; F:GTP binding; IEA:UniProtKB-KW.
DR   GO; GO:0003924; F:GTPase activity; IBA:GO_Central.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   GO; GO:0005047; F:signal recognition particle binding; IBA:GO_Central.
DR   GO; GO:0006613; P:cotranslational protein targeting to membrane; TAS:ProtInc.
DR   GO; GO:0006886; P:intracellular protein transport; IEA:InterPro.
DR   GO; GO:0045047; P:protein targeting to ER; IBA:GO_Central.
DR   GO; GO:0006617; P:SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition; NAS:ComplexPortal.
DR   CDD; cd14826; SR_alpha_SRX; 1.
DR   CDD; cd17876; SRalpha_C; 1.
DR   DisProt; DP00893; -.
DR   Gene3D; 3.30.450.60; -; 1.
DR   Gene3D; 3.40.50.300; P-loop containing nucleotide triphosphate hydrolases; 1.
DR   Gene3D; 1.20.120.140; Signal recognition particle SRP54, nucleotide-binding domain; 1.
DR   InterPro; IPR003593; AAA+_ATPase.
DR   InterPro; IPR011012; Longin-like_dom_sf.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR007222; Sig_recog_particle_rcpt_asu_N.
DR   InterPro; IPR013822; Signal_recog_particl_SRP54_hlx.
DR   InterPro; IPR036225; SRP/SRP_N.
DR   InterPro; IPR000897; SRP54_GTPase_dom.
DR   InterPro; IPR042101; SRP54_N_sf.
DR   PANTHER; PTHR43134; SIGNAL RECOGNITION PARTICLE RECEPTOR SUBUNIT ALPHA; 1.
DR   PANTHER; PTHR43134:SF1; SIGNAL RECOGNITION PARTICLE RECEPTOR SUBUNIT ALPHA; 1.
DR   Pfam; PF04086; SRP-alpha_N; 1.
DR   Pfam; PF00448; SRP54; 1.
DR   Pfam; PF02881; SRP54_N; 1.
DR   SMART; SM00382; AAA; 1.
DR   SMART; SM00962; SRP54; 1.
DR   SMART; SM00963; SRP54_N; 1.
DR   SUPFAM; SSF47364; Domain of the SRP/SRP receptor G-proteins; 1.
DR   SUPFAM; SSF52540; P-loop containing nucleoside triphosphate hydrolases; 1.
DR   SUPFAM; SSF64356; SNARE-like; 1.
DR   PROSITE; PS00300; SRP54; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Endoplasmic reticulum; GTP-binding;
KW   Membrane; Nucleotide-binding; Phosphoprotein; Receptor; Reference proteome.
FT   CHAIN           1..638
FT                   /note="Signal recognition particle receptor subunit alpha"
FT                   /id="PRO_0000101213"
FT   REGION          132..244
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          283..316
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          419..636
FT                   /note="NG domain"
FT                   /evidence="ECO:0000303|PubMed:34020957"
FT   COMPBIAS        132..176
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        204..244
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        283..314
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         425..432
FT                   /ligand="GTP"
FT                   /ligand_id="ChEBI:CHEBI:37565"
FT                   /evidence="ECO:0000250"
FT   BINDING         520..524
FT                   /ligand="GTP"
FT                   /ligand_id="ChEBI:CHEBI:37565"
FT                   /evidence="ECO:0000250"
FT   BINDING         588..591
FT                   /ligand="GTP"
FT                   /ligand_id="ChEBI:CHEBI:37565"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         177
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         284
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:24275569"
FT   MOD_RES         296
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:24275569"
FT   MOD_RES         297
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:24275569"
FT   MOD_RES         298
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:24275569"
FT   MOD_RES         473
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         578
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   VAR_SEQ         40..67
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_046055"
FT   MUTAGEN         407
FT                   /note="R->A: Reduced SR compaction. Impaired interaction
FT                   with SRP. Impaired detachement from ribosome. Does not
FT                   impair GTP hydrolysis by the SRP-SR complex."
FT                   /evidence="ECO:0000269|PubMed:34020957"
FT   CONFLICT        81
FT                   /note="K -> R (in Ref. 1; CAA29608)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        201
FT                   /note="G -> E (in Ref. 1; CAA29608)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        306..307
FT                   /note="NS -> TL (in Ref. 1; CAA29608)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        632
FT                   /note="V -> L (in Ref. 2; BAG64435)"
FT                   /evidence="ECO:0000305"
FT   STRAND          3..9
FT                   /evidence="ECO:0007829|PDB:2FH5"
FT   STRAND          12..19
FT                   /evidence="ECO:0007829|PDB:2FH5"
FT   TURN            20..22
FT                   /evidence="ECO:0007829|PDB:2FH5"
FT   HELIX           28..35
FT                   /evidence="ECO:0007829|PDB:2FH5"
FT   HELIX           37..39
FT                   /evidence="ECO:0007829|PDB:2FH5"
FT   STRAND          53..59
FT                   /evidence="ECO:0007829|PDB:2FH5"
FT   TURN            60..63
FT                   /evidence="ECO:0007829|PDB:2FH5"
FT   STRAND          64..71
FT                   /evidence="ECO:0007829|PDB:2FH5"
FT   HELIX           73..75
FT                   /evidence="ECO:0007829|PDB:2FH5"
FT   HELIX           76..93
FT                   /evidence="ECO:0007829|PDB:2FH5"
FT   HELIX           95..99
FT                   /evidence="ECO:0007829|PDB:2FH5"
FT   STRAND          100..102
FT                   /evidence="ECO:0007829|PDB:2FH5"
FT   HELIX           104..107
FT                   /evidence="ECO:0007829|PDB:2FH5"
FT   HELIX           114..127
FT                   /evidence="ECO:0007829|PDB:2FH5"
FT   HELIX           332..351
FT                   /evidence="ECO:0007829|PDB:6Y32"
FT   HELIX           356..370
FT                   /evidence="ECO:0007829|PDB:6Y32"
FT   HELIX           378..397
FT                   /evidence="ECO:0007829|PDB:6Y32"
FT   HELIX           405..415
FT                   /evidence="ECO:0007829|PDB:6Y32"
FT   STRAND          419..424
FT                   /evidence="ECO:0007829|PDB:6Y32"
FT   HELIX           431..444
FT                   /evidence="ECO:0007829|PDB:6Y32"
FT   STRAND          449..454
FT                   /evidence="ECO:0007829|PDB:6Y32"
FT   HELIX           461..472
FT                   /evidence="ECO:0007829|PDB:6Y32"
FT   HELIX           473..475
FT                   /evidence="ECO:0007829|PDB:6Y32"
FT   HELIX           478..481
FT                   /evidence="ECO:0007829|PDB:6Y32"
FT   STRAND          486..490
FT                   /evidence="ECO:0007829|PDB:6Y32"
FT   STRAND          494..496
FT                   /evidence="ECO:0007829|PDB:6Y32"
FT   HELIX           498..512
FT                   /evidence="ECO:0007829|PDB:6Y32"
FT   STRAND          515..521
FT                   /evidence="ECO:0007829|PDB:6Y32"
FT   HELIX           529..542
FT                   /evidence="ECO:0007829|PDB:6Y32"
FT   STRAND          545..552
FT                   /evidence="ECO:0007829|PDB:6Y32"
FT   HELIX           558..572
FT                   /evidence="ECO:0007829|PDB:6Y32"
FT   STRAND          576..578
FT                   /evidence="ECO:0007829|PDB:6Y32"
FT   STRAND          584..588
FT                   /evidence="ECO:0007829|PDB:6Y32"
FT   HELIX           590..592
FT                   /evidence="ECO:0007829|PDB:5L3Q"
FT   HELIX           599..606
FT                   /evidence="ECO:0007829|PDB:6Y32"
FT   STRAND          611..615
FT                   /evidence="ECO:0007829|PDB:6Y32"
FT   STRAND          617..619
FT                   /evidence="ECO:0007829|PDB:6Y32"
FT   HELIX           628..637
FT                   /evidence="ECO:0007829|PDB:6Y32"
SQ   SEQUENCE   638 AA;  69811 MW;  967F943CEE3FA79E CRC64;
     MLDFFTIFSK GGLVLWCFQG VSDSCTGPVN ALIRSVLLQE RGGNNSFTHE ALTLKYKLDN
     QFELVFVVGF QKILTLTYVD KLIDDVHRLF RDKYRTEIQQ QSALSLLNGT FDFQNDFLRL
     LREAEESSKI RAPTTMKKFE DSEKAKKPVR SMIETRGEKP KEKAKNSKKK GAKKEGSDGP
     LATSKPVPAE KSGLPVGPEN GVELSKEELI RRKREEFIQK HGRGMEKSNK STKSDAPKEK
     GKKAPRVWEL GGCANKEVLD YSTPTTNGTP EAALSEDINL IRGTGSGGQL QDLDCSSSDD
     EGAAQNSTKP SATKGTLGGM FGMLKGLVGS KSLSREDMES VLDKMRDHLI AKNVAADIAV
     QLCESVANKL EGKVMGTFST VTSTVKQALQ ESLVQILQPQ RRVDMLRDIM DAQRRQRPYV
     VTFCGVNGVG KSTNLAKISF WLLENGFSVL IAACDTFRAG AVEQLRTHTR RLSALHPPEK
     HGGRTMVQLF EKGYGKDAAG IAMEAIAFAR NQGFDVVLVD TAGRMQDNAP LMTALAKLIT
     VNTPDLVLFV GEALVGNEAV DQLVKFNRAL ADHSMAQTPR LIDGIVLTKF DTIDDKVGAA
     ISMTYITSKP IVFVGTGQTY CDLRSLNAKA VVAALMKA
//
DBGET integrated database retrieval system